Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Barnett

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Psychiatric Practice|March 25, 2024
Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid PlansBrian S Barnett,
Journal of Psychopharmacology (Oxford, England)|September 16, 2022
Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and HealthBrian S Barnett
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding StrategyBrian S Barnett, Andrey Ostrovsky
Journal of Psychoactive Drugs|November 26, 2020
Dissemination of Erroneous Research Findings and Subsequent Retraction in High-Circulation Newspapers: A Case Study of Alleged MDMA-Induced Dopaminergic Neurotoxicity in PrimatesBrian S Barnett, Richard Doblin
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A PrimerBrian S Barnett, George R Greer
The Journal of Nervous and Mental Disease|July 1, 2020
A Survey of American Psychiatrists Concerning Medication Prior Authorization RequirementsBrian S Barnett, J Alexander Bodkin
Cleveland Clinic Journal of Medicine|March 3, 2025
Psychedelic-assisted therapy: An overview for the internistBrian S Barnett, Erin E Mauney, Franklin King
Journal of Psychoactive Drugs|October 11, 2022
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical StudiesJeremy Weleff, Teddy J Akiki, Brian S Barnett
Psychedelic Medicine (New Rochelle, N.Y.)|June 18, 2025
Ensuring Access to Psychedelic-Assisted Therapy in Rural CommunitiesOlivia M Dhaliwal, Lukas Bobak, Brian S Barnett
Substance Abuse|March 20, 2019
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case reportHeather Burrell Ward, Brian S Barnett, Joji Suzuki
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Psychiatric Practice|March 25, 2024
Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid PlansBrian S Barnett,
Journal of Psychopharmacology (Oxford, England)|September 16, 2022
Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and HealthBrian S Barnett
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding StrategyBrian S Barnett, Andrey Ostrovsky
Journal of Psychoactive Drugs|November 26, 2020
Dissemination of Erroneous Research Findings and Subsequent Retraction in High-Circulation Newspapers: A Case Study of Alleged MDMA-Induced Dopaminergic Neurotoxicity in PrimatesBrian S Barnett, Richard Doblin
Journal of the Academy of Consultation-Liaison Psychiatry|July 2, 2021
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A PrimerBrian S Barnett, George R Greer
The Journal of Nervous and Mental Disease|July 1, 2020
A Survey of American Psychiatrists Concerning Medication Prior Authorization RequirementsBrian S Barnett, J Alexander Bodkin
Cleveland Clinic Journal of Medicine|March 3, 2025
Psychedelic-assisted therapy: An overview for the internistBrian S Barnett, Erin E Mauney, Franklin King
Journal of Psychoactive Drugs|October 11, 2022
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical StudiesJeremy Weleff, Teddy J Akiki, Brian S Barnett
Psychedelic Medicine (New Rochelle, N.Y.)|June 18, 2025
Ensuring Access to Psychedelic-Assisted Therapy in Rural CommunitiesOlivia M Dhaliwal, Lukas Bobak, Brian S Barnett
Substance Abuse|March 20, 2019
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case reportHeather Burrell Ward, Brian S Barnett, Joji Suzuki
Pageof 6